Loading…
Loading the latest PSX data…
Loading the latest PSX data…
IBL HealthCare Limited (IBLHL), GlaxoSmithKline Pakistan Limited (GLAXO): performance, valuation, growth, risk and danioPSX score, side by side.
Add a stock
Growth of Rs 100 from 2025-11-11
Daily closes from PSX end-of-day files, adjusted for bonus shares, right issues and splits (not for cash dividends). KSE-100: official closes where available, otherwise rebuilt from its constituents.
| Measure | IBLHLPharmaceuticals | GLAXOPharmaceuticals |
|---|---|---|
| danioPSX score | 15 | 89 |
| Price and size | ||
| Price | Rs 40.40 | Rs 335.70 |
| Today | −1.27% | −1.15% |
| Market cap | Rs 4.0bn | Rs 106.9bn |
| Traded per day | Rs 4m | Rs 49m |
| Valuation and dividends | ||
| P/E | 18.5 | 9.7 |
| Dividend yield | – | 6.1% |
| EPS (last year) | Rs 2.24 | Rs 31.48 |
| Business | ||
| EPS growth | +6.2% | +53.4% |
| Sales growth | +6.6% | +7.7% |
| Net margin | 4.8% | 15.2% |
| Returns | ||
| 1 month | −1.3% | +8.9% |
| 3 months | −15.6% | −1.6% |
| 1 year | −18.3% | −13.9% |
| vs KSE-100, 1 year | -31.4 pts | -27.0 pts |
| Trend and risk | ||
| 52-week position | 10% | 28% |
| RSI 14 | 51 | 65 |
| RS rank | 19 | 42 |
| Volatility | 56% | 34% |
| Beta | 1.13 | 1.05 |
| danioPSX score | ||
| Value | 23 | 69 |
| Quality | 58 | 81 |
| Dividend | 0 | 64 |
| Momentum | 21 | 40 |
| Safety | 23 | 80 |
| Shariah-compliant | Yes | Yes |
Bold marks the best value in each row where higher (or, for P/E and volatility, lower) is clearly better.
A comparison of published numbers, not a recommendation. Share this page: the address holds the stocks. Find more stocks with the screener